The antidepressant effectiveness of transcranial magnetic stimulation is not impacted by comorbid neurotic, stress-related or somatoform disorders
Comorbid F4-diagnoses do not affect the antidepressant efficacy of TMS. iTBS is as effective as other protocols, but shorter and more cost-efficient, making it preferable for patients and providers.
Authors
- Milena Engelke (ORCID: https://orcid.org/0000-0002-7346-0441)
- Mohamed A. Abdelnaim (ORCID: https://orcid.org/0000-0002-8766-674X)
- Stefan Schoisswohl (ORCID: https://orcid.org/0000-0003-3633-999X)
- Katharina Kerkel (ORCID: https://orcid.org/0009-0001-2372-0778)
- Lea Steinecker
Institutions
- University Hospital Regensburg (DE)
- University of Regensburg (DE)
Publication Details
- Journal
- Journal of Affective Disorders
- Published
- 2026-02-21
- DOI
- https://doi.org/10.1016/j.jad.2026.121479
- Primary Topic
- Transcranial Magnetic Stimulation Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00